Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
14/02/2024 22:56
Feb 14 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PROVIDES UPDATE ON RESULTS FROM PRE-IND ENABLING
STUDIES
* AMPIO PHARMACEUTICALS INC - COMPANY'S MANAGEMENT AND BOARD
ARE
CURRENTLY ASSESSING BOTH INTERNAL AND EXTERNAL OPTIONS
* AMPIO PHARMACEUTICALS INC - WILL BE TAKING IMMEDIATE
ACTIONS TO
PRESERVE ITS CASH
* AMPIO PHARMACEUTICALS- BELIEVE NEED TO SHOW STATISTICALLY
SIGNIFICANT IMPROVEMENT IN PAIN REDUCTION & CARTILAGE PROTECTION
TO SUPPORT IND FOR OA-201
Source text for Eikon: ID:nPn9xzryla
Further company coverage: AMPE.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank